Mineralys Therapeutics
MLYS
MLYS
94 hedge funds and large institutions have $517M invested in Mineralys Therapeutics in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 48 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.56% more ownership
Funds ownership: 84.37% → 88.92% (+4.6%)
2% more funds holding
Funds holding: 92 → 94 (+2)
4% less capital invested
Capital invested by funds: $541M → $517M (-$24M)
Holders
94
Holding in Top 10
6
Calls
$217K
Puts
$19K
Top Buyers
| 1 | +$8.73M | |
| 2 | +$8.22M | |
| 3 | +$7.99M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6.73M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$4.96M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$7.17M | |
| 3 | -$4.84M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.53M |
| 5 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$2.2M |